nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.218	0.258	CbGbCtD
Trimipramine—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.181	0.214	CbGbCtD
Trimipramine—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.176	0.208	CbGbCtD
Trimipramine—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.166	0.196	CbGbCtD
Trimipramine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.105	0.125	CbGbCtD
Trimipramine—Benazepril—ACE—focal segmental glomerulosclerosis	0.00444	0.466	CrCbGaD
Trimipramine—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.0511	CcSEcCtD
Trimipramine—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.0028	0.0397	CcSEcCtD
Trimipramine—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.0367	CcSEcCtD
Trimipramine—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.0333	CcSEcCtD
Trimipramine—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.0333	CcSEcCtD
Trimipramine—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.0321	CcSEcCtD
Trimipramine—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00219	0.0309	CcSEcCtD
Trimipramine—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.0296	CcSEcCtD
Trimipramine—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.0238	CcSEcCtD
Trimipramine—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.0234	CcSEcCtD
Trimipramine—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.0226	CcSEcCtD
Trimipramine—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.0225	CcSEcCtD
Trimipramine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.0225	CcSEcCtD
Trimipramine—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.0224	CcSEcCtD
Trimipramine—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.0224	CcSEcCtD
Trimipramine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.0205	CcSEcCtD
Trimipramine—Oxcarbazepine—ALB—focal segmental glomerulosclerosis	0.00138	0.145	CrCbGaD
Trimipramine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.0192	CcSEcCtD
Trimipramine—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.0191	CcSEcCtD
Trimipramine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.0184	CcSEcCtD
Trimipramine—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.0182	CcSEcCtD
Trimipramine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.0176	CcSEcCtD
Trimipramine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.0169	CcSEcCtD
Trimipramine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.0168	CcSEcCtD
Trimipramine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.0167	CcSEcCtD
Trimipramine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.0165	CcSEcCtD
Trimipramine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.0162	CcSEcCtD
Trimipramine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.0156	CcSEcCtD
Trimipramine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.0155	CcSEcCtD
Trimipramine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.0152	CcSEcCtD
Trimipramine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.0151	CcSEcCtD
Trimipramine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0149	CcSEcCtD
Trimipramine—Acepromazine—ALB—focal segmental glomerulosclerosis	0.00104	0.11	CrCbGaD
Trimipramine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.0148	CcSEcCtD
Trimipramine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.0147	CcSEcCtD
Trimipramine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0143	CcSEcCtD
Trimipramine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000987	0.014	CcSEcCtD
Trimipramine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000937	0.0133	CcSEcCtD
Trimipramine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00093	0.0132	CcSEcCtD
Trimipramine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000921	0.013	CcSEcCtD
Trimipramine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000911	0.0129	CcSEcCtD
Trimipramine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.0009	0.0127	CcSEcCtD
Trimipramine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000893	0.0126	CcSEcCtD
Trimipramine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000885	0.0125	CcSEcCtD
Trimipramine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000853	0.0121	CcSEcCtD
Trimipramine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000823	0.0116	CcSEcCtD
Trimipramine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000819	0.0116	CcSEcCtD
Trimipramine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000819	0.0116	CcSEcCtD
Trimipramine—Clomipramine—ALB—focal segmental glomerulosclerosis	0.000794	0.0834	CrCbGaD
Trimipramine—Nortriptyline—ALB—focal segmental glomerulosclerosis	0.000776	0.0815	CrCbGaD
Trimipramine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000743	0.0105	CcSEcCtD
Trimipramine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000733	0.0104	CcSEcCtD
Trimipramine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000708	0.01	CcSEcCtD
Trimipramine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000685	0.00969	CcSEcCtD
Trimipramine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000658	0.00931	CcSEcCtD
Trimipramine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000653	0.00924	CcSEcCtD
Trimipramine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000652	0.00923	CcSEcCtD
Trimipramine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000649	0.00918	CcSEcCtD
Trimipramine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000615	0.0087	CcSEcCtD
Trimipramine—Chlorpromazine—ALB—focal segmental glomerulosclerosis	0.000544	0.0572	CrCbGaD
Trimipramine—Amitriptyline—ALB—focal segmental glomerulosclerosis	0.000538	0.0566	CrCbGaD
Trimipramine—ADRA1B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	7.05e-05	0.000969	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	7.05e-05	0.000969	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	7.03e-05	0.000966	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	7e-05	0.000962	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	7e-05	0.000961	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	6.99e-05	0.00096	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	6.98e-05	0.000959	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	6.97e-05	0.000957	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.97e-05	0.000957	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.93e-05	0.000952	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	6.92e-05	0.00095	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	6.88e-05	0.000945	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	6.85e-05	0.000941	CbGpPWpGaD
Trimipramine—SLC6A2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	6.76e-05	0.000929	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.73e-05	0.000925	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	6.73e-05	0.000924	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	6.69e-05	0.00092	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	6.57e-05	0.000903	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	6.57e-05	0.000903	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—ALB—focal segmental glomerulosclerosis	6.56e-05	0.000901	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	6.51e-05	0.000894	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	6.5e-05	0.000894	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	6.46e-05	0.000887	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	6.43e-05	0.000883	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	6.41e-05	0.00088	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	6.4e-05	0.000879	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	6.39e-05	0.000877	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	6.37e-05	0.000875	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	6.35e-05	0.000873	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	6.35e-05	0.000872	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	6.34e-05	0.000871	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	6.28e-05	0.000863	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	6.27e-05	0.000861	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	6.25e-05	0.000858	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	6.22e-05	0.000855	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.21e-05	0.000853	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.11e-05	0.000839	CbGpPWpGaD
Trimipramine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	6.1e-05	0.000839	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.09e-05	0.000837	CbGpPWpGaD
Trimipramine—SLC6A3—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	5.99e-05	0.000823	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—FN1—focal segmental glomerulosclerosis	5.99e-05	0.000823	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	5.98e-05	0.000822	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	5.98e-05	0.000821	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—NOS2—focal segmental glomerulosclerosis	5.92e-05	0.000813	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	5.91e-05	0.000812	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	5.91e-05	0.000812	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.83e-05	0.0008	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	5.82e-05	0.0008	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	5.81e-05	0.000799	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	5.8e-05	0.000797	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	5.78e-05	0.000794	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	5.7e-05	0.000784	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	5.69e-05	0.000782	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	5.67e-05	0.00078	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	5.56e-05	0.000763	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	5.51e-05	0.000758	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	5.43e-05	0.000746	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	5.43e-05	0.000745	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	5.41e-05	0.000744	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	5.4e-05	0.000742	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.38e-05	0.00074	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.35e-05	0.000736	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.33e-05	0.000732	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	5.31e-05	0.00073	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	5.29e-05	0.000726	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	5.21e-05	0.000716	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.2e-05	0.000714	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	5.19e-05	0.000713	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.17e-05	0.00071	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.17e-05	0.00071	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.14e-05	0.000706	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—LIPC—focal segmental glomerulosclerosis	5.03e-05	0.000692	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	5.01e-05	0.000688	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	4.98e-05	0.000685	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—ALB—focal segmental glomerulosclerosis	4.97e-05	0.000684	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	4.96e-05	0.000682	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.95e-05	0.00068	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	4.94e-05	0.000678	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.93e-05	0.000677	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.92e-05	0.000676	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.92e-05	0.000676	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.9e-05	0.000674	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.89e-05	0.000672	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.82e-05	0.000663	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	4.74e-05	0.000652	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.73e-05	0.00065	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.71e-05	0.000647	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	4.58e-05	0.000629	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.56e-05	0.000627	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.54e-05	0.000623	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.52e-05	0.000621	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.51e-05	0.000619	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	4.5e-05	0.000619	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.5e-05	0.000618	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	4.49e-05	0.000617	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.49e-05	0.000617	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.48e-05	0.000616	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.48e-05	0.000616	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.46e-05	0.000613	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.46e-05	0.000612	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.45e-05	0.000612	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	4.43e-05	0.000609	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	4.41e-05	0.000606	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.4e-05	0.000604	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.38e-05	0.000602	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.37e-05	0.000601	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.34e-05	0.000597	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.32e-05	0.000594	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.18e-05	0.000575	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.16e-05	0.000571	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.15e-05	0.00057	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—TGFB1—focal segmental glomerulosclerosis	4.15e-05	0.00057	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.14e-05	0.000569	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.12e-05	0.000566	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	4.1e-05	0.000563	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.09e-05	0.000562	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.09e-05	0.000561	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.08e-05	0.000561	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.08e-05	0.000561	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.06e-05	0.000558	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4e-05	0.00055	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.97e-05	0.000546	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.95e-05	0.000543	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.81e-05	0.000524	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.81e-05	0.000524	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.78e-05	0.00052	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.75e-05	0.000516	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.75e-05	0.000515	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.75e-05	0.000515	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.72e-05	0.000511	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.68e-05	0.000505	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	3.57e-05	0.00049	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.49e-05	0.00048	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.49e-05	0.000479	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.48e-05	0.000478	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.46e-05	0.000476	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.43e-05	0.000472	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.43e-05	0.000471	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.41e-05	0.000469	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.39e-05	0.000465	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.37e-05	0.000463	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.36e-05	0.000462	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.35e-05	0.000461	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	3.28e-05	0.000451	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.27e-05	0.000449	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	3.25e-05	0.000447	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.25e-05	0.000447	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.21e-05	0.000441	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.21e-05	0.000441	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.21e-05	0.000441	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	3.15e-05	0.000432	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	3.14e-05	0.000431	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.12e-05	0.000429	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.11e-05	0.000428	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.1e-05	0.000425	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.08e-05	0.000423	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	3.07e-05	0.000422	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	3.07e-05	0.000421	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.98e-05	0.000409	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.96e-05	0.000406	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.95e-05	0.000405	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.93e-05	0.000402	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.91e-05	0.0004	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.9e-05	0.000399	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.9e-05	0.000398	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.89e-05	0.000398	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	2.89e-05	0.000397	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.88e-05	0.000396	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.87e-05	0.000394	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	2.86e-05	0.000393	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.85e-05	0.000392	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.82e-05	0.000388	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.82e-05	0.000388	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.82e-05	0.000387	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.8e-05	0.000384	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.78e-05	0.000382	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.77e-05	0.00038	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.72e-05	0.000373	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.68e-05	0.000368	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.67e-05	0.000367	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.67e-05	0.000367	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.66e-05	0.000366	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.66e-05	0.000366	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.65e-05	0.000364	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.64e-05	0.000362	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	2.63e-05	0.000361	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.62e-05	0.00036	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.58e-05	0.000355	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.57e-05	0.000353	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.57e-05	0.000353	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.46e-05	0.000338	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.46e-05	0.000337	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.43e-05	0.000334	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.42e-05	0.000332	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.41e-05	0.000331	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.37e-05	0.000325	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.27e-05	0.000312	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.23e-05	0.000307	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.23e-05	0.000306	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.23e-05	0.000306	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.21e-05	0.000303	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.2e-05	0.000302	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.19e-05	0.0003	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	2.18e-05	0.000299	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.15e-05	0.000295	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	2.15e-05	0.000295	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.14e-05	0.000294	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	2.12e-05	0.000292	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.05e-05	0.000281	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.03e-05	0.000279	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	2.02e-05	0.000277	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	2e-05	0.000275	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	1.98e-05	0.000273	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.89e-05	0.000259	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.89e-05	0.000259	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	1.86e-05	0.000256	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.86e-05	0.000255	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.85e-05	0.000255	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.82e-05	0.00025	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.82e-05	0.00025	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	1.82e-05	0.00025	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.74e-05	0.000239	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	1.71e-05	0.000235	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.71e-05	0.000234	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	1.7e-05	0.000233	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.69e-05	0.000232	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.65e-05	0.000226	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.64e-05	0.000225	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.57e-05	0.000215	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.45e-05	0.000199	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	1.43e-05	0.000196	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.42e-05	0.000195	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.42e-05	0.000195	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.41e-05	0.000193	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	1.39e-05	0.000192	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.39e-05	0.000191	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.36e-05	0.000186	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.35e-05	0.000186	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	1.31e-05	0.000181	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.31e-05	0.00018	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	1.3e-05	0.000179	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.29e-05	0.000178	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.29e-05	0.000178	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.19e-05	0.000164	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.17e-05	0.000161	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.17e-05	0.000161	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.15e-05	0.000158	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	1.12e-05	0.000154	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.07e-05	0.000147	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	8.59e-06	0.000118	CbGpPWpGaD
